Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Nov 15, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present virtually at the Evercore ISI 5th Annual HealthCONx Conference on...
-
Nov 10, 2022
Execution of BD 2025 Strategy Driving Consistent Durable Growth Q4 revenue from continuing operations of $4.8 billion decreased 1.8% as reported and increased 2.3% on a currency-neutral basis Q4...
-
Nov 10, 2022
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, an increase of 4.6% from the previous quarter. The dividend...
-
Nov 2, 2022
Ridgewood, NJ, November 2, 2022 – Valley-Mount Sinai Comprehensive Cancer Care is pleased to be the recipient of a $652,000 grant over three years from BD (Becton, Dickinson and Company), a...
-
Oct 26, 2022Conforms to Independently Audited International Standards for Information Security: ISO/IEC 27001:2022
FRANKLIN LAKES, N.J. (Oct. 26, 2022) – BD (Becton, Dickinson and Company), a leading global medical technology company, today announced its enterprise-level Information Security Management...
-
Oct 18, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Magnolia Medical Technologies, Inc., today announced a co-exclusive commercial agreement aimed at...
-
Oct 17, 2022BD, Biocorp Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable DrugsCompanies to Explore Opportunities to Integrate Biocorp’s Injay® Technology with BD UltraSafePlus™ Passive Needle Guard to Help Biopharmaceutical Manufacturers Capture and Transmit Self-Administered Injection Data.
FRANKLIN LAKES, N.J. (October 17, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biocorp, a medical device and delivery systems...
-
Oct 13, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will report its fiscal 2022 fourth quarter and full year financial results on Thursday, November 10, 2022. A news release...
-
Oct 11, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Forbes' 2022 list of the World's Best Employers. "Empowering our teams to excel in...
-
Oct 3, 2022
FRANKLIN LAKES, N.J. (Oct. 3, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Eric Borin has been named president of...
-
Sep 29, 2022
Public-Private Partnership Supporting Diagnostic Testing in Vulnerable Communities has Provided $2.6 Million to U.S. Clinics Since 2017 to Help Improve Patient Outcomes and Health Equity FRANKLIN...
-
Sep 27, 2022
Diagnostic Research Center Enables Students to Test and Develop Clinical Workflows to Help Shape Laboratory Performance and Patient Outcomes FRANKLIN LAKES, N.J., Sept. 27, 2022 /PRNewswire/ -- BD...
-
Sep 27, 2022
New BD® Research Cloud provides scientists with an integrated ecosystem that allows for optimizing panel design, collaboration and analysis FRANKLIN LAKES, N.J., Sept. 27, 2022 /PRNewswire/ -- BD...
-
Sep 26, 2022
Research Use Only (RUO) assay now globally available for BD MAX™ System FRANKLIN LAKES, N.J., Sept. 26, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global...
-
Sep 19, 2022
Announcement Made at Clinton Global Initiative 2022 Commits $360,000 to Support Nurses in Africa FRANKLIN LAKES, N.J., Sept. 19, 2022 /PRNewswire/ -- The BD Foundation, the philanthropic arm of...
-
Sep 13, 2022
BD EffivaxTM Glass Prefillable Syringe Features Enhanced Technology that Builds on Company's Decades of Expertise in the Prefillable Syringe Market and Supports Customers' Manufacturing Needs...
-
Sep 8, 2022
Puneet Sarin Named President of Medication Management Solutions Steve Conly Named President of Biosciences FRANKLIN LAKES, N.J. (Sept. 8, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX),...
-
Aug 25, 2022
Mike Garrison Named EVP and President, Medical segment Rick Byrd Named EVP and President, Interventional segment FRANKLIN LAKES, N.J., Aug. 25, 2022 /PRNewswire/ -- BD (Becton, Dickinson and...
-
Aug 24, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo 2022 Healthcare Conference on Wednesday,...
-
Aug 22, 2022
Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced the consideration payable in connection with its previously announced Tender Offers (as defined below) to purchase...
-
Aug 22, 2022
Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced the early tender results for its previously announced Tender Offers (as defined below) to purchase for cash...
-
Aug 18, 2022
First patient enrollment in PREVISION trial marks opportunity to further advance the safety and performance of drug-coated balloon technology and aligns with the company’s commitment to...
-
Aug 15, 2022
Companies will work together to bring rapid antimicrobial identification and susceptibility diagnostics to more clinicians and patients worldwide FRANKLIN LAKES, N.J. and TUCSON, Ariz., Aug. 15,...
-
Aug 9, 2022
Companies combine key capabilities to advance flow cytometry as an essential companion diagnostic modality for cancer and other diseases FRANKLIN LAKES, N.J., Aug. 9, 2022 /PRNewswire/ -- BD...
-
Aug 8, 2022
Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced that it has commenced tender offers to purchase for cash the debt securities issued by the Company listed in the...
-
Aug 8, 2022
Funding to Four Community Health Centers Advances Medication Management Programs for Vulnerable Patients Managing Chronic Disease FRANKLIN LAKES, N.J., Aug. 8, 2022 /PRNewswire/ -- BD (Becton,...
-
Aug 4, 2022
Revenue from continuing operations of $4.6 billion increased 0.7% as reported and 3.8% on currency-neutral basis Revenue from continuing operations driven by base revenue growth of 6.0% as...
-
Jul 28, 2022
Acquisition adds to company's recent growth in high-technology pharmacy solutions and further accelerates the company's commitment to Smart, Connected Care – offering a customizable platform to...
-
Jul 27, 2022
Research Use Only (RUO) assay now available for BD MAX™ System users FRANKLIN LAKES, N.J., July 27, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical...
-
Jul 26, 2022
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.87 per common share, payable on September 30, 2022 to holders of record on...
-
Jul 20, 2022
Top Score on Disability Equality Index Demonstrates Progress in Removing Barriers and Creating Employment Opportunities for People with Disabilities FRANKLIN LAKES, N.J., July 20, 2022...
-
Jul 19, 2022
FRANKLIN LAKES, N.J. (July 19, 2022) — Recent research published in the Journal of the American College of Clinical Pharmacy shows that investments made in clinical pharmacist-led patient care...
-
Jul 18, 2022
- BD enters growing pharmacy automation market segment by offering a comprehensive set of technologies across the care continuum - Addition of Parata aligns with two key tenets of BD's innovation...
-
Jul 7, 2022
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report financial results for its third quarter of fiscal year 2022 on Thursday, August 4, 2022. A news release will be...
-
Jul 5, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Rishi Grover has been named executive vice president (EVP) and chief integrated...
-
Jul 5, 2022
Company makes notable progress toward 2030+ ESG commitments, addressing energy, water and waste reduction, environmental impact of product portfolio and supplier diversification FRANKLIN LAKES, N.J.,
-
Jun 30, 2022
BD MAX™ Molecular Diagnostic Respiratory Viral Panel CE Marked to IVD Directive FRANKLIN LAKES, N.J., June 30, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading...
-
Jun 28, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today unveiled findings from a survey conducted by The Harris...
-
Jun 22, 2022
BD (Becton, Dickinson and Company), a leading global medical technology company, announced a voluntary recall on the BD™ Intraosseous Needle Set Kits, BD™ Intraosseous Manual Driver Kits and...
-
Jun 13, 2022
BD is among the first companies to enter innovative partnership with Mayo Clinic Platform for access to world's largest collection of clinical data FRANKLIN LAKES, N.J., June 13, 2022 /PRNewswire/...
-
Jun 8, 2022
CerTest Biotec Uses the BD MAX™ Molecular Diagnostic System Open System Reagent Suite to Develop RT-PCR Detection Kit ZARAGOZA, Spain and FRANKLIN LAKES, N.J., June 8, 2022 /PRNewswire/ --...
-
Jun 7, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has appointed Simon Campion as executive vice president (EVP) and president of the...
-
Jun 6, 2022
Expands BD Transformative Solutions to Provide New Pharmacy Automation Technologies for Hospitals, Retail Pharmacy, Long-Term Care and Home Settings Advances BD 2025 Strategy to Accelerate...
-
Jun 3, 2022
BD FACSDiscover™ S8 Cell Sorter with BD CellView™ Image Technology First to Combine Spectral Flow Cytometry with Sort-Capable Imaging FRANKLIN LAKES, N.J., June 3, 2022 /PRNewswire/ -- BD...
-
Jun 2, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Goldman Sachs 43rd Annual Global Healthcare Conference on...
-
May 26, 2022
Second Test for the BD COR™ MX to be CE Marked to IVD Directive FRANKLIN LAKES, N.J., May 26, 2022 / B3C newswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical...
-
May 18, 2022Companies to work together with the aim of optimizing advanced technologies for use in prefillable syringes
FRANKLIN LAKES, N.J. (May 18, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Mitsubishi Gas Chemical Company, Inc. (MGC), a R&D-oriented...
-
May 13, 2022Named a “Noteworthy Company” for Third Straight Year
FRANKLIN LAKES, N.J. (May 13, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been named a “Noteworthy...
-
May 12, 2022
BD First Participant in Intermountain’s ‘Impact Hire’ Program for Strategic Suppliers SALT LAKE CITY (May 12, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global...
-
May 12, 2022
510(k) Clearance of BD COR™ MX Instrument Elevates Standard of Care for Sexually Transmitted Infections FRANKLIN LAKES, N.J., May 12, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company)...